Malignant Pleural Mesothelioma May Be Effectively Treated with Combined...
Using a dual therapeutic approach targeting both MET and PI3K signaling pathways is more effective in treating malignant pleural mesothelioma (MPM) cells than using each inhibitor alone, according to a...
View ArticleCrizotinib-Afatinib Combination Halves Mesothelioma Growth in Mice, Study Shows
A combination of crizotinib and afatinib does a better job of inhibiting the growth of malignant pleural mesothelioma (MPM) cancer cells than either therapy alone, according to a study. Together, the...
View ArticleCrizotinib-Afatinib Combination Halves Mesothelioma Growth in Mice, Study Shows
A combination of crizotinib and afatinib does a better job of inhibiting the growth of malignant pleural mesothelioma (MPM) cancer cells than either therapy alone, according to a study. Together, the...
View Article
More Pages to Explore .....